Multiple Myeloma
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
From the Journals
Most Cancer Trial Centers Located Closer to White, Affluent Populations
Researchers compare the distributions of patients of different races and socioeconomic statuses to the locations of clinical research facilities...
Commentary
New Drug Approvals Are the Wrong Metric for Cancer Policy
How should we define success in cancer policy — what should the endpoint be?
Feature
Extraordinary Patients Inspired Father of Cancer Immunotherapy
Renowned researcher, Dr. Steven A. Rosenberg, describes his path to pioneering the use of immunotherapies in treating cancer.
News
Myeloma: FDA Advisers Greenlight Early CAR-T
ODAC voted 11-0 in support of expanded cilta-cel use, 8-3 for expanded ide-cel use, while urging clearer warning about the risks of these drugs....
From the Journals
Consider These Factors in an Academic Radiation Oncology Position
Editorial gives guidance to radiation oncologists seeking academic positions.
Feature
Look Beyond BMI: Metabolic Factors’ Link to Cancer Explained
A snapshot assessment of metabolic syndrome is inadequate to show an association with cancer risk over time, the authors of new research say.
Feature
ASTRO Pushes Return to Direct Supervision in RT: Needed or ‘Babysitting’?
But some radiation oncologists do not agree with the proposal to move back to direct in-person supervision only.
Conference Coverage
High Marks for New CAR T Toxicity Grading Tool
A real-world study demonstrates the benefits of a new grading system to assess hematotoxicities across disease types following CAR T-cell...
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...
News from the FDA/CDC
FDA Removes Harmful Chemicals From Food Packaging
The “major source of dietary exposure to PFAS from food packaging” is being eliminated.